Asensus Surgical (FRA:2TX) Long-Term Capital Lease Obligation : €4.05 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Asensus Surgical Long-Term Capital Lease Obligation?

Asensus Surgical's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €4.05 Mil.

Asensus Surgical's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (€4.29 Mil) to Dec. 2023 (€4.26 Mil) and declined from Dec. 2023 (€4.26 Mil) to Mar. 2024 (€4.05 Mil).

Asensus Surgical's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (€4.43 Mil) to Dec. 2022 (€4.47 Mil) but then declined from Dec. 2022 (€4.47 Mil) to Dec. 2023 (€4.26 Mil).

Asensus Surgical Long-Term Capital Lease Obligation Historical Data

The historical data trend for Asensus Surgical's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asensus Surgical Long-Term Capital Lease Obligation Chart

Asensus Surgical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.52

4.43

4.47

4.26

Asensus Surgical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															4.27	4.30	4.29	4.26	4.05

Asensus Surgical (FRA:2TX) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Asensus Surgical Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Asensus Surgical's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Asensus Surgical (FRA:2TX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Asensus Surgical Inc (FRA:2TX) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

ASXC:USA

Address

1 TW Alexander Drive, Suite 160, Durham, NC, USA, 27703

Website

https://www.asensus.com

Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.

Asensus Surgical (FRA:2TX) Headlines

No Headlines